Views & Analysis Getting patients round the virtual table If pharma wants to be truly patient-centric, it needs to be talking to patients.
Views & Analysis Why pharma needs to care about global warming Barely a day goes by without global warming or climate change (now more appropriately termed “climate crisis” by some media outlets) being in the news.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
